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The ability to provide quantitative,
objective and automated pathological
analysis would provide enormous ben-
efits for national cancer screening pro-
grammes, in terms of both resource
reduction and improved patient well-
being. The move towards molecular
pathology through spectroscopic
methods shows great promise, but has
been restricted by spectral quality,
acquisition times and lack of direct
clinical application. In this paper, we
present the application of wavelength modulated Raman spectroscopy for the auto-
mated label- and fluorescence-free classification of fixed squamous epithelial cells
in suspension, such as those produced during a cervical smear test. Direct compar-
ison with standard Raman spectroscopy shows marked improvement of sensitivity
and specificity when considering both human papillomavirus (sensitivity +12.0%,
specificity +5.3%) and transformation status (sensitivity +10.3%, specificity
+11.1%). Studies on the impact of intracellular sampling location and storage
effects suggest that wavelength modulated Raman spectroscopy is sufficiently
robust to be used in fixed cell classification, but requires further investigations of
potential sources of molecular variation in order to improve current clinical tools.
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1 | INTRODUCTION
The introduction of national screening programmes such as
the Papanicoloau (‘Pap’) test and mammogram have
achieved considerable success, and are estimated to prevent,
for example, 4500 [1] and 1300 [2] deaths in the United
Kingdom every year from cervical and breast cancer,
respectively. However, these programmes require large,
sustained financial input and human resources and are not
completely accurate. The primary purpose of cervical
screening is to detect abnormal epithelial cells that indicate
the presence of cervical pre-cancer or cancer. In a cervical
screen, cells are brushed from the cervix and stored in fix-
ing solution as a liquid-based cytology sample. This ‘smear’
is transferred to a microscope slide, stained and viewed by a
cytopathologist, who classifies it as normal, borderline, low
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or high grade dyskaryosis, glandular neoplasia or unsatisfac-
tory [3]. However, interpretation of cell morphology is
hugely complex and therefore, open to subjectivity and false
diagnosis, as small numbers of abnormal epithelial cells
must be identified in a background of numerous normal epi-
thelial and inflammatory cells. In 2008, clinical trial com-
paring reviewed with initial pre-treatment histologic
diagnosis, the probability of unnecessary treatment was
found to be 8% to 27% (dependent on initial cytologic find-
ings) [4], indicating that many women may be being
referred to colposcopy unnecessarily. The use of biomarker
screening has been posited as a potential method for
improving diagnostic accuracy, but identifying targets rele-
vant to genetically heterogeneous populations exposed to a
variety of environmental factors while maintaining high-
positive predictive value is often unfeasible [5]. Thus, a
technique which provides the benefits of quantitative molec-
ular pathology but with a broader scope and automated clas-
sification could vastly improve screening outcomes.
One technique with the potential to deliver these charac-
teristics is Raman spectroscopy. Raman spectroscopy is a
label-free technique based on the inelastic scattering of
light. It can be used to identify the molecular vibrational
bonds present in a sample. Changes in disease state are
accompanied by alterations in molecular pathology, which
are reflected in spectral data. Raman spectroscopy in its var-
ious forms is emerging as a key contender for analysis of
cancer status [6], including colorectal [7], lung [8] and cer-
vical cancer [9–11]. However, the likelihood of clinical
uptake is highly dependent upon the ability to contend with
the practicality as well as accuracy of diagnostic gold stan-
dards such as histopathology. As such, a new classification
method would need to be incorporated into current systems
for trials to be conducted in the first instance.
In this paper, we demonstrate the use of wavelength
modulated Raman spectroscopy (WMRS) [12] as a tool for
the automated classification of unlabeled fixed cells in sus-
pension, reflecting its potential utility in diagnosing clinical
liquid-based cytology samples. One of the major technical
barriers to the introduction of Raman spectroscopy as a clin-
ical tool is the long acquisition time associated with the rare
event of Raman scattering of photons. The acquisition of
high-quality spectra is further compounded by the presence
of autofluorescence in samples, which is a particular prob-
lem for biological interrogation and can often lead to the
loss of smaller Raman peaks obscured by a fluorescent
background. Several approaches for reducing the back-
ground have been explored, including post-acquisition
baseline correction, nonlinear optical methods and time-,
frequency- and wavelength-domain methods [13].
WMRS is a wavelength-domain approach. During mea-
surement, the laser wavelength is modulated throughout the
acquisition process using a tunable laser [14]. This causes
the Raman spectral peaks to shift fractionally when measured
in terms of scattered wavelength. When this shift is measured
across several wavelengths, a ‘differential spectrum’ can be
generated which demonstrates the true Raman peaks in
wavenumber shift from the incident wavelength. Wavelength
modulation does not affect the position of autofluorescence
from the sample and substrate, allowing the background to
be automatically removed [12]. Methods for post-processing
wavelength modulated spectra in order to account for wave-
length shift and remove this static fluorescence background
have been tested, including standard excitation Raman dif-
ference spectroscopy, SD, Fourier filtering, least-squares fit
and principal component analysis (PCA), with PCA provid-
ing the best signal-to-noise ratio [15]. The differential
Raman spectrum is formed from the first principal compo-
nent (PC) of the modulated data set, corresponding to the
component which captures the greatest variance in the data.
This method has been used to investigate single living
Chinese Hamster Ovary cells (CHO-K1) [12] as well as T
lymphocytes (CD4+, CD8+), killer T cells (CD56+) and
dendritic cells (CD303+, CD1c+) [16]. It has also been
shown to provide high specificity and sensitivity for the
characterisation of human urothelial (SV-HUC-1) and blad-
der cancer (MGH) cell lines cultured normally [14] or
exposed to urine [17], which represents another step
towards an automated optical platform for cancer screening.
The aim of this study is to assess the practical potential of
WMRS as a method for the automated classification of
fixed squamous epithelial cells, modelling cervical cancer
diagnosis.
2 | MATERIALS AND METHODS
2.1 | Cell sample preparation
A total of 4 established cell lines, and primary cells, from
squamous epithelial tissue were used for this project, reflect-
ing the intention to investigate WMRS as a method of clas-
sifying cervical smear samples. CaSki, SiHa, C33A (all
squamous cell carcinoma, adult human cervix), HaCaT
(immortalised squamous epithelium, adult human skin) and
primary normal human epidermal keratinocytes (‘NHEKs’,
normal squamous epithelium, neonatal human skin) were
cultured to 80% to 90% confluency. These were harvested
by trypsinisation, washed in triplicate by centrifugation and
resuspension in sterilised phosphate buffered saline (PBS),
and fixed in the clinical methanol-based fixative PreservCyt.
Samples were stored in PreservCyt at −20∘C until use. All
centrifugation steps were executed at 400. for 5 minutes at
4∘C. Prior to interrogation, fixed cell samples were washed
in triplicate by centrifugation and resuspension in sterilised
PBS in order to remove traces of fixing solution, as metha-
nol produces strong Raman signatures. Twenty microliter of
PBS cell suspension was then transferred to a quartz cavity
slide (Figure 1), carefully sealed with a 150 μm quartz
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coverslip and inverted. The quartz assemblies were rested
for at least 20 minutes prior to interrogation in order to pro-
mote cell adherence to the quartz coverslip, which was
placed face down on the inverted microscope assembly for
measurement. Details of the origin and cell culture reagents
used for each cell type are provided in Appendix S1,
Table 1.
2.2 | Spectral acquisition
A confocal Raman microscope built and modified for acqui-
sition of both standard and modulated spectra (Figure 2)
was used to evaluate the fixed cell samples. Raman spectra
were generated from individual cells inside the quartz cavity
assembly using a tunable continuous wave Ti-Sapphire laser
(‘SolsTis’, M Squared Laser Ltd, maximum power 1 W at
785 nm), delivering 150 mW power in a 1 μm spot in the
sample plane through a 40× oil immersion objective
(Nikon, NA1.3). A translational stage allowed the laser to
be focused on the nuclear region of each cell, with Raman
scattered photons collected from a confocal collection vol-
ume 2.86 μm in depth and 2.63 μm in diameter about the
laser spot. The signal was resolved with a Shamrock SR-
303i spectrometer (400 lines/mm grating, Andor Technol-
ogy) and collected with a CCD camera (Newton, Andor
Technology) thermoelectrically cooled to −70∘C. ‘Standard’
spontaneous and wavelength modulated Raman spectra
were acquired using Solis (s) Software (Andor Technology)
along with a brightfield microscope image (Imaging Source
USB Camera) of each cell (see Supplementary Information
S3). Standard acquisitions were conducted at 785 nm, using
5 accumulations of 2 seconds laser exposure for both the
cell and adjacent background. The adjacent background,
including any spectral contribution from the quartz slide,
was removed from the raw cell spectrum for data analysis.
In the modulated acquisitions, 5 accumulations of 2 seconds
exposures were performed with 5 different cycles of excita-
tion wavelengths over a total range of Δλ = 1 nm centred at
785 nm. No background acquisition was necessary here due
to the inherent autofluorescence removal. It has been shown
previously that no significant phototoxicity was experienced
by the cells as a result of laser exposure at similar set-
tings [16].
Reference spectra for laser calibration were acquired
from 1 μm polystyrene beads in distilled water. These
spectra were used to account for fluctuations in laser power,
wavelength and spot location due to heating, fibre-optic
coupling or mirror alignment, as well as post-acquisition
spectral processing.
2.3 | Spectral processing and data analysis
All spectra were considered in the fingerprint region of
interest, 800 to 1800 cm−1. Spectra were normalised
according to the total area under each modulation set, which
is linearly proportional to the laser power. Laser wavelength
was also monitored by linearly interpolating the intensity
and Raman shift of the characteristic 1001.4 cm−1 polysty-
rene peak according to the sample measurement time stamp
and adjusting spectral position accordingly. Overall, this
accounts for any laser power and wavelength fluctuations
over time, thereby preventing the PCA script from grouping
cells according to these parameters. Immediately prior to
analysis, individual spectra were assessed and removed
from the analysis if a high spectral background was appar-
ent. Such artefacts arise from suboptimal focusing or cell
movement during acquisition. All spectra were analysed
using PCA, a commonly used multivariate spectral analysis
technique [18]. PCA breaks spectra down into orthogonal
spectral components PCs which describe the variation in the
dataset. The first principal component describes the greatest
variation, with higher components eventually describing
noise [19]. The first 7 PCs were used in all data analysis
conducted. The weighting of these PCs (the extent to which
each PC represents a particular spectrum in the dataset) was
used to generate PCA cluster plots, which may be used for
diagnostic classification. Sensitivity and specificity values
were generated through ‘leave-one-out cross-validation
(LOOCV)’, also known as a ‘jacknife’ [18]. When per-
formed for 2 datasets, the classifications can be quantita-
tively estimated as sensitivity and specificity values by
assigning the each cell line as ‘positive’ or ‘negative’. Sta-
tistically significant variations between spectra were also
estimated for each cell line pair using student's . test at a
significance level of . < 10−12. This was conducted using
the established ‘ttest2’ function in MATLAB, where the
average spectral intensity at each wavenumber is compared,
with consideration to spectral variation across the dataset
(indicated in figures by coloured bands around the average).
The PCA script used was written in MATLAB by the Bio-
photonics Group at the University of St Andrews.
3 | RESULTS
3.1 | Comparison of human papillomavirus status
A preliminary comparison of standard and wavelength mod-
ulated Raman spectroscopy as a classification tool was
made using fixed C33A human papillomavirus (HPV
FIGURE 1 The cavity slide assembly used for all acquisitions. Slides
were sterilised with ethanol, air-dried and polished in between
measurements
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negative) and SiHa (HPV16 positive) cells, kindly donated
by the Scottish HPV Archive [20]. The samples were resus-
pended in PBS and prepared for analysis as described in
Section 2.1. Initial analysis of the C33A cell line found that
an acquisition time of 2 seconds over 5 accumulations
yielded superior standard Raman spectra to a single acquisi-
tion of 10seconds. This is due to a comparative reduction in
CCD camera noise for the shorter acquisitions. The bright-
field cell images were morphologically similar, consisting
of 10 μm cells which were highly rounded due to the trypsi-
nisation process. The PCA plots for the standard and modu-
lated Raman can be seen in Figure 3. LOOCV was applied
to the datasets to yield sensitivity values of 88.0% and
100.0% for standard and modulated Raman, respectively,
representing a considerable improvement of 12%. Specific-
ities of 90.5% and 95.8% were found for standard and mod-
ulated Raman respectively, or a 5.3% improvement. It is
clear from both PCA and LOOCV that modulated Raman
spectroscopy provides a superior separation and classifica-
tion of 2 cervical carcinoma cell lines with differing HPV
status. The main spectral disparities occur at approximately
730, 760, 890, 920, 1130, 1250, 1380 and 1480 cm−1.
3.2 | Comparison of different status in squamous
epithelial cell lines
The investigation of standard and modulated Raman spec-
troscopy was then extended to 4 cell lines (1 normal,
1 immortalised and 2 transformed), which were chosen to
represent the spectrum of abnormality typically found in the
progression to cervical cancer. NHEKs are normal squa-
mous epithelial cells which stop dividing when they reach a
certain age. HaCaT cells [21] are a spontaneously
immortalised epithelial line which can proliferate beyond
this normal limit. These were used as a model for cervical
precancer. SiHa [22] and CaSki [23] are cervical cancer cell
lines from primary and metastatic tumours, respectively.
These are both transformed phenotypes, consisting of cells
capable of forming tumours. A total of 163 cells were inter-
rogated using both standard and wavelength modulated
Raman spectroscopy, consisting of 42 NHEK, 41 SiHa,
40 CaSki and 40 HaCaT cells. As before, the established
cell lines in particular could not be discerned on a purely
morphological basis, which furthers the case for biochemi-
cal classification as a complementary technique. It must be
noted that the morphology of the primary NHEK cells var-
ied significantly in terms of both shape and size compared
to the established cell lines. Following removal of subopti-
mal spectra, Raman spectra and PCA plots were generated
as seen in Figures 4 and 5, respectively. The ability of PCA
to act as a classification algorithm was explored using
cross-validation of the data. LOOCV was performed on all
4 cell lines for both datasets; the confusion matrices for
standard and modulated PCA can be seen in Table 1 and 2,
respectively, along with misclassification statistics. For all
3 established cell lines, the modulated spectra provide better
discrimination. However, classification is slightly superior
using standard Raman spectra for NHEKs.
In order to gain further understanding of both the effi-
cacy of the test and the major vibrational signals contribut-
ing to the analysis, each possible pair combination of cell
lines was analysed using the PCA script. The average sensi-
tivity was 84.8%  9.0. and 95.1%  5.6., and specificity
was 85.1%  10.7. and 96.2%  4.6., for standard and
modulated PCA respectively. This demonstrates that, for
both metrics, wavelength modulated Raman spectroscopy
FIGURE 2 The optical diagram of the
spectrometer designed for WMRS and
standard Raman spectral acquisition.
Brightfield microscope images are acquired
separately on CCD1 and blocked from the
spectrometer by secondary EF
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provides superior discrimination (+10.3% sensitivity,
+11.1% specificity) as well as lower variation between cell
types. The generated spectra were also marked with signifi-
cance bands as decribed in Section 2.3. Spectra with marked
bands are shown for NHEK-Siha, NHEK-CaSki and
NHEK-HaCaT are shown in Figures 6 and 7. The . test sta-
tistics used did not identify any bands for the combination
HaCaT-SiHa, for either standard or modulated Raman. The
lack of statistically significant spectral differences here
explain the reduced classification accuracy for the 4 cell line
validation, where the largest populations of misidentified
cells were from the HaCaT-SiHa pairing. A lack of signifi-
cant spectral differences may suggest that mechanisms
behind the biological similarities between these 2 cell lines
(eg, their ability to proliferate indefinitely) make a greater
contribution to the Raman spectra than those characteristics
which constitute a difference (such as DNA content). Signifi-
cance bands for HaCaT-CaSki and SiHa-CaSki were only
seen for the modulated Raman dataset, again suggesting that
the application of PCA to differential spectra provides more
FIGURE 3 Standard (A) and modulated
(B) spectral datapoints represented as PC1/2
weightings for C33A (HPV negative
carcinoma) and SiHa (HPV-16 carcinoma)
cells. The number of cells used for each
comparison are indicated in the legend
FIGURE 4 (A) Standard and (B) modulated
Raman spectral averages for the 4 cell lines
used, 800 to 1800 cm−1
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useful information than traditional approaches. Prior to con-
sideration of significance bands, it can be seen in the stan-
dard Raman spectra that for each comparison of NHEKs to
the 3 established cell lines, the same peaks are demonstrating
significant change. The peak at approximately 1590 cm−1
(adenine/guanine) only appears for the established cell lines,
although significant difference is seen only for NHEK-
HaCaT here. It is interesting that the largest peak at approxi-
mately 1450 cm−1 (CH2/CH3 deformation of lipids/colla-
gen/other hydrocarbon modes) is significant for NHEK-
HaCaT (normal vs immortalised) but not for the standard
normal vs. transformed cell types (NHEK against SiHa or
CaSki). The modulated NHEK-CaSki comparison shows
several significant spectral differences not seen in the
remaining comparisons. The statistically significant bands
and tentative peak assignments based on previous literature
[9, 24] are shown in Appendix S2, Table 2.
Overall, it is clear that the use of a differential spectrum
in modulated Raman spectroscopy highlights different sta-
tistically significant regions of the spectrum in comparison
to standard Raman spectra. Due to the format of the differ-
ential spectrum, real Raman peaks correspond to differential
zero-crossing points. Therefore differential spectral variation
represents subtle alterations in the shape, slope and position
of peak ‘shoulders’ as opposed to absolute peak height and
position. Small variations in these parameters result from
FIGURE 5 (A) Standard and (B) modulated
PCA weightings for the 4 cell lines used.
Variation in the number of datapoints used
arises from the rejection of different spectra in
each set
TABLE 1 The confusion matrix resulting from cross-validation of
standard Raman PCA, with accompanying percentage classification
accuracy
Predicted
Actual NHEK SiHa CaSki HaCaT Class acc. (%)
NHEK 31 2 1 1 88.6
SiHa 2 25 6 7 62.5
CaSki 1 9 19 10 48.7
HaCaT 3 9 6 22 55.0
TABLE 2 The confusion matrix resulting from cross-validation of
modulated Raman PCA, with accompanying percentage classification
accuracy
Predicted
Actual NHEK SiHa CaSki HaCaT Class acc. (%)
NHEK 29 4 0 1 85.3
SiHa 1 32 0 8 78.0
CaSki 0 1 38 0 97.4
HaCaT 0 2 0 38 95.0
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changes to the population of a molecular group (in the case
where multiple Raman peaks occupy the same region) or
changes to the environment of a bond. This may lead to a
significant increase in utility for the differential spectrum
approach in biological contexts, as Raman peaks frequently
overlap and biological changes are often the result of alter-
ations in molecular conformation in addition to type (as is
the case for protein conformation or DNA packaging). The
only regions which were statistically significant for all stan-
dard Raman spectral comparisons were those corresponding
to Amide I:β-sheet/C-O stretch/ν(C-C) and Amide III:α-
helix/collagen/CH in phospholipids/C-C in fatty acids. It is
suggested that the increased density of protein conforma-
tional changes may arise from histones [9]. Many of the
remaining significant peak differences also result from
DNA-associated structures, including DNA O-P-O back-
bone stretching and polynucleotide chains. The only differ-
ential region which demonstrated statistically significant
variations in each case was that of the symmetric ring
breathing mode of phenylalanine and tryptophan.
3.3 | Impact of intracellular variation
It was previously found that the Raman spectra for intracel-
lular locations in CHO-K1 cells were very distinct, with the
nucleus providing the optimum signal-to-noise ratio [12].
However, that data was generated from adherent cells
grown directly onto glass slides, giving the characteristic
flattened morphology associated with cells in culture. This
distinctive morphology did not translate to the spectral
acquisitions from fixed cells considered in this article: the
cell rounding effects associated with trypsinisation and fix-
ing made the consistent identification of intracellular organ-
elles challenging. Typical brightfield images are shown in
Appendix S3, Figure 1. To investigate the importance of
intracellular location on characterisation, further samples of
the Section 3.2 cell lines were fixed and each cell interro-
gated multiple times at locations designated as cell wall,
cytoplasm, nucleus and nucleolus. Typical images are
shown in Appendix S3, Figure 2. Cells were rejected if the
specified components could not be discerned clearly. The
nucleolus was identified as a high-density sphere within the
nuclear volume. All 4 datasets were recorded in the modu-
lated setup only and analysed as discussed previously.
Figure 8 shows the overall PCA plot from the cells, disre-
garding laser spot location. The resulting confusion matrix
and classifications are detailed in Appendix S3, Table 3.
Despite some misclassifications (particularly for NHEKs),
the average predictive accuracy is high at 91.2%. The
FIGURE 6 Direct comparison of the standard
spectra for NHEK against the remaining
established cell lines SiHa, CaSki and HaCaT.
Shaded bands refer to regions of statisitically
significant difference (student's . test) between
the spectral intensities
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analysis can then be expanded to consider location for each
cell line in turn. This can be seen for the SiHa line in
Figure 9—the remaining expanded PCA plots can be seen
in Appendix S3, Figures 3–5. The classification accuracies
for the location-specific subset of each expanded matrix are
summarised in Table 3. These are much lower and more
variable than both classifications by cell line and location-
based results from de Luca et al. experiment [12], suggest-
ing that there is insufficient spectral disparity to separate
clusters by location when rounded cells are interrogated in
solution.
As such, the matrices were then considered by grouping
points according to their location inside (nucleus, nucleolus)
or outside (cytoplasm, cell wall) the nucleus. The
FIGURE 8 The PCA plot for the overall
classification of cell lines without
consideration of location
FIGURE 7 Direct comparison of the
modulated spectra for NHEK against the
remaining established cell lines SiHa, CaSki
and HaCaT. Shaded bands refer to regions of
statisitically significant difference (student's
t test) between the spectral intensities
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summarised classification accuracies shown in Table 4. The
resulting accuracies from this test indicate that there is suffi-
cient spectral difference to separate these location clusters
from inside and outside the nucleus with an accuracy
approaching that of cell line classification. However, the
fixed cells do not provide sufficient spectral difference to
account for specific cellular regions with the accuracy seen
for adherent cells interrogated directly on their culture sub-
strates. Thus, cell shape and sampling method should be a
key consideration for sampling location accuracy.
3.4 | Impact of other variation sources
Finally, the potential effects of storage time on spectral clas-
sification were investigated. Recent work by Hobro
et al. considered spectral differences between live mouse
embryonic fibroblast cells and those fixed with different
agents, including methanol [25]. Methanol acts as both a
fixing and permeabilisatio n agent which dehydrates cells
and precipitates proteins. In that case, a significant loss of
overall Raman signal was observed in cells fixed with meth-
anol, which were mostly associated with lipid bands. The
effects of storage in fixative were not considered by Hobro
et al. Based on the routine morphological and genomic anal-
ysis of stored smear samples without alterations to data, we
hypothesised that changes over time after initial fixation
would not be significant. If such changes do occur, it would
have considerable impact on the use of Raman spectroscopy
as a tool for clinical sample classification where samples
may be archived in fixing solution for long periods of time
either before analysis, for revisiting borderline samples or
for comparing with new samples for disease progression. A
total of 150 cells were interrogated from SiHa cell samples
which had been stored at −20C for 3 days, 1 month or
6 months in PreservCyt before following the same protocols
described previously. The average Raman spectra are in
Figure 10. Pairwise comparisons of each sample type as
FIGURE 9 The PCA plot for classification
where SiHa cells have been considered in
terms of sampling by nucleus, nucleolus,
cytoplasm or cell wall. The remaining
location-expanded plots can be found in
Appendix S3
TABLE 3 The percentage classification accuracies for the cell lines by
intracellular location. The average classification error is a single SD from
the mean
Classification accuracy (%)
Loc. NHEK SiHa CaSki HaCaT Average
Nucleus 50 60 50 60 55  5
Nucleolus 50 20 50 80 50  21
Cytoplasm 44 88 44 80 64  20
Cell wall 60 50 60 80 63  11
TABLE 4 The percentage classification accuracies for the cell lines based
on location in reference to the nucleus. The average classification error is a
single SD from the mean
Classification accuracy (%)
Loc. NHEK SiHa CaSki HaCaT Average
Inside 93.3 90.0 90.0 94.1 91.9  1.9
Outside 88.9 86.7 77.8 100.0 88.4  7.9
FIGURE 10 Average spectra of 50 cells from
each sample, stored in PreservCyt for 3 days,
1 month or 6 months
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conducted before revealed significant differences between
3 days and 1 month cells, and between 1 and 6 months
cells, but not between the 1 day and 6 months cells. These
differences occur in both the former cases at 992 to
997 cm−1 (ring breathing of tryptophan/phenylalanine),
1595 cm−1 (adenine/guanine) and 1715 cm−1 (C=O, lipids).
None of these bands were indicated in the live-fixed cell
comparison for methanol [25]. Figure 11 shows the corre-
sponding PCA plot, where grouping can be seen clearly for
the 3 days and 6 months clusters in the PC1/PC2 and
PC2/PC3 projections. The confusion matrix (Table 5) for
the 3 days and 6 months samples are consistent with the
hypothesis that no changes should occur during storage, as
classification accuracy is low. However, the 1 month sam-
ple shows high-classification accuracy, which indicates that
there are sufficient spectral differences to classify these
nominally identical cells in relation to the remaining sam-
ples. The lack of trend according to storage time suggests
that while storage should not be an issue for classification,
other sources of variation are present and can be detected
by the WMRS.
4 | DISCUSSION
In Sections 3.1 and 3.2, the comparisons of standard and
modulated methods for spectral acquisition clearly demon-
strate that WMRS is able to provide superior cell classifica-
tion accuracy. The ability to discriminate between HPV
positive and negative cervical carcinoma cell lines is an
encouraging step towards the potential integration of HPV
and smear testing using optical discrimination. However, it
must be noted that these carcinoma lines represent different
mechanisms of origin, and by extension molecular patholo-
gies. The ability to also identify HPV status in normal cervi-
cal cells would be a requirement of an integrated platform
and so this will require consideration. The presence of sig-
nificant spectral differences only in the modulated Raman
acquisition between SiHa and CaSki cells, which represent
primary and metastatic cervical carcinoma respectively, also
points towards greater clinical utility for the sampling
method and resulting spectral analysis. The investigation of
location impact for spectral sampling provides important
data regarding the expected differences between sampling
particular cell morphologies or methods of collection. It is
suggested that the lower specificity of sampling location for
fixed cells in suspension compared to previous experiments
with adherent, plated cells is due to the superposition of
spectral data from different components of the cell, as the
surface area occupied by the cell is lower. This lower mar-
gin of error could provide benefits for coupling the spec-
trometer with automated cell sampling capabilities, and will
have to be taken into consideration for clinical samples
acquired with a cytology brush. Finally, although overall
cell classification was unaffected by storage time in fixative,
the relationship between spectral characteristics and fixation
was complex, consistent with recent evidence that methanol
fixatives affect spectral data, particularly in relation to lipid
peaks [25]. The sensitivity of the technique to these changes
suggests that similar issues with sample heterogeneity will
have to be addressed with large clinical datasets.
5 | CONCLUSION
In this study, fluorescence-free wavelength modulated
Raman spectroscopy has been used to consider the benefits
and practicalities of such a system in the context of label-
free classification of fixed cell samples, such as those from
cervical screening. The use of wavelength modulation in
FIGURE 11 The PCA plot of the 3
‘archived’ fixed samples, stored for different
periods of time
TABLE 5 The confusion matrix resulting from cross-validation of the
fixed cell storage time dataset, with accompanying percentage classification
accuracy
Predicted
Actual 3 d 1 mo 6 mo Class acc. (%)
3 d 29 0 21 58.0
1 mo 1 47 2 94.0
6 mo 17 1 32 64.0
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Raman spectroscopy and the resulting removal of autofluor-
escence provides clear benefits to its ability to automatically
classify cells over conventional Raman scattering, without
the requirement for manual baseline fitting, additional lasers
or optical gates. It is entirely feasible that the technique
could be combined with other imaging methods such as
optical coherence tomography [26] or digital holographic
microscopy [27] in order to provide a cell ‘topography’ map
for automated point sampling. It is hoped that such a system
could be introduced to clinical settings in order to reduce
the burden on manual cytological diagnosis, as well as
increasing the likelihood of a correct outcome for patients.
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